Dare Bioscience, Inc. Accrued Royalties, Current
Dare Bioscience, Inc. (DARE) had Accrued Royalties, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2025-03-31
- 2024-12-31: Accrued Royalties, Current $0.00.
- 2023-12-31: Accrued Royalties, Current $6.50K.
- 2022-12-31: Accrued Royalties, Current $0.00.
| Period end | Accrued Royalties, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-12-31 | $6.50K 10-K · filed 2025-03-31 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |